544 related articles for article (PubMed ID: 15886118)
21. An APRIL to remember: novel TNF ligands as therapeutic targets.
Dillon SR; Gross JA; Ansell SM; Novak AJ
Nat Rev Drug Discov; 2006 Mar; 5(3):235-46. PubMed ID: 16474316
[TBL] [Abstract][Full Text] [Related]
22. BAFF/BLyS receptor 3 comprises a minimal TNF receptor-like module that encodes a highly focused ligand-binding site.
Gordon NC; Pan B; Hymowitz SG; Yin J; Kelley RF; Cochran AG; Yan M; Dixit VM; Fairbrother WJ; Starovasnik MA
Biochemistry; 2003 May; 42(20):5977-83. PubMed ID: 12755599
[TBL] [Abstract][Full Text] [Related]
23. APRIL and TALL-I and receptors BCMA and TACI: system for regulating humoral immunity.
Yu G; Boone T; Delaney J; Hawkins N; Kelley M; Ramakrishnan M; McCabe S; Qiu WR; Kornuc M; Xia XZ; Guo J; Stolina M; Boyle WJ; Sarosi I; Hsu H; Senaldi G; Theill LE
Nat Immunol; 2000 Sep; 1(3):252-6. PubMed ID: 10973284
[TBL] [Abstract][Full Text] [Related]
24. The crystal structure of a proliferation-inducing ligand, APRIL.
Wallweber HJ; Compaan DM; Starovasnik MA; Hymowitz SG
J Mol Biol; 2004 Oct; 343(2):283-90. PubMed ID: 15451660
[TBL] [Abstract][Full Text] [Related]
25. Activation and accumulation of B cells in TACI-deficient mice.
Yan M; Wang H; Chan B; Roose-Girma M; Erickson S; Baker T; Tumas D; Grewal IS; Dixit VM
Nat Immunol; 2001 Jul; 2(7):638-43. PubMed ID: 11429549
[TBL] [Abstract][Full Text] [Related]
26. TACI and BAFF-R mediate isotype switching in B cells.
Castigli E; Wilson SA; Scott S; Dedeoglu F; Xu S; Lam KP; Bram RJ; Jabara H; Geha RS
J Exp Med; 2005 Jan; 201(1):35-9. PubMed ID: 15630136
[TBL] [Abstract][Full Text] [Related]
27. TACI-ligand interactions are required for T cell activation and collagen-induced arthritis in mice.
Wang H; Marsters SA; Baker T; Chan B; Lee WP; Fu L; Tumas D; Yan M; Dixit VM; Ashkenazi A; Grewal IS
Nat Immunol; 2001 Jul; 2(7):632-7. PubMed ID: 11429548
[TBL] [Abstract][Full Text] [Related]
28. BAFF costimulation of Toll-like receptor-activated B-1 cells.
Ng LG; Ng CH; Woehl B; Sutherland AP; Huo J; Xu S; Mackay F; Lam KP
Eur J Immunol; 2006 Jul; 36(7):1837-46. PubMed ID: 16791880
[TBL] [Abstract][Full Text] [Related]
29. The role of BAFF in immune function and implications for autoimmunity.
Kalled SL
Immunol Rev; 2005 Apr; 204():43-54. PubMed ID: 15790349
[TBL] [Abstract][Full Text] [Related]
30. The role of the BAFF/APRIL system on T cell function.
Mackay F; Leung H
Semin Immunol; 2006 Oct; 18(5):284-9. PubMed ID: 16931039
[TBL] [Abstract][Full Text] [Related]
31. The role of the BAFF/APRIL system in B cell homeostasis and lymphoid cancers.
Mackay F; Tangye SG
Curr Opin Pharmacol; 2004 Aug; 4(4):347-54. PubMed ID: 15251127
[TBL] [Abstract][Full Text] [Related]
32. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.
Morimoto S; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Nakiri Y; Suzuki J; Nozawa K; Amano H; Tokano Y; Kobata T; Takasaki Y
Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077
[TBL] [Abstract][Full Text] [Related]
33. Age-related changes in BAFF and APRIL profiles and upregulation of BAFF and APRIL expression in patients with primary antibody deficiency.
Jin R; Kaneko H; Suzuki H; Arai T; Teramoto T; Fukao T; Kondo N
Int J Mol Med; 2008 Feb; 21(2):233-8. PubMed ID: 18204790
[TBL] [Abstract][Full Text] [Related]
34. Expression and function of TNF family member B cell-activating factor in the development of autoimmune arthritis.
Zhang M; Ko KH; Lam QL; Lo CK; Srivastava G; Zheng B; Lau YL; Lu L
Int Immunol; 2005 Aug; 17(8):1081-92. PubMed ID: 16000326
[TBL] [Abstract][Full Text] [Related]
35. BAFF AND APRIL: a tutorial on B cell survival.
Mackay F; Schneider P; Rennert P; Browning J
Annu Rev Immunol; 2003; 21():231-64. PubMed ID: 12427767
[TBL] [Abstract][Full Text] [Related]
36. Crystal structure of the BAFF-BAFF-R complex and its implications for receptor activation.
Kim HM; Yu KS; Lee ME; Shin DR; Kim YS; Paik SG; Yoo OJ; Lee H; Lee JO
Nat Struct Biol; 2003 May; 10(5):342-8. PubMed ID: 12715002
[TBL] [Abstract][Full Text] [Related]
37. Interferon-beta increases BAFF levels in multiple sclerosis: implications for B cell autoimmunity.
Krumbholz M; Faber H; Steinmeyer F; Hoffmann LA; Kümpfel T; Pellkofer H; Derfuss T; Ionescu C; Starck M; Hafner C; Hohlfeld R; Meinl E
Brain; 2008 Jun; 131(Pt 6):1455-63. PubMed ID: 18474519
[TBL] [Abstract][Full Text] [Related]
38. Expression and occupancy of BAFF-R on B cells in systemic lupus erythematosus.
Carter RH; Zhao H; Liu X; Pelletier M; Chatham W; Kimberly R; Zhou T
Arthritis Rheum; 2005 Dec; 52(12):3943-54. PubMed ID: 16320342
[TBL] [Abstract][Full Text] [Related]
39. B cell activation through CD40 and IL4R ligation modulates the response of chronic lymphocytic leukaemia cells to BAFF and APRIL.
Ferrer G; Bosch R; Hodgson K; Tejero R; Roué G; Colomer D; Montserrat E; Moreno C
Br J Haematol; 2014 Feb; 164(4):570-8. PubMed ID: 24245956
[TBL] [Abstract][Full Text] [Related]
40. Increased BCMA expression in lupus marks activated B cells, and BCMA receptor engagement enhances the response to TLR9 stimulation.
Kim J; Gross JA; Dillon SR; Min JK; Elkon KB
Autoimmunity; 2011 Mar; 44(2):69-81. PubMed ID: 21250838
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
